The European Commission has launched a consultation on proposals to “recalibrate” supplementary protection certificates and patent research exemptions.
The European Commission has launched a consultation that could pave the way for new measures that would update the supplementary protection certificate (SPC) system, including a unitary SPC and an SPC manufacturing waiver for export purposes. It says the findings will help it determine whether the EU SPC framework is still fit for purpose.
Through its consultation the commission wants to better understand stakeholder experience and knowledge of SPCs with a view to introducing...
<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>
As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.
<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.
